Attempts to develop treatment in HGPS associated with progerin accumulation may thus rely on a multi-targetted approach, including decreased progerin production, increased degradation, or downstream noxious cascades (4). This evidence concerns the gene LMNA and Hutchinson-Gilford progeria syndrome.